DRKS00030736招募中Unknown
Scientific evaluation of a telemedical psychological intervention to promote smoking cessation in patients with peripheral arterial occlusive disease
niklinik RWTH Aachen0 个研究点目标入组 826 人开始时间: 2023年3月6日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 826
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 80 Years(—)
- 性别
- All
入选标准
- •Participants will only be included if patient documentation at one of the recruitment hospitals proves that the following criteria are met at the time of enrollment: 1. Patient is between = 18 and = 80 years old. 2. Patient is mentally and physically capable of understanding the study's meaning and scope and can follow the investigators' instructions. 3. The patient's written informed consent was obtained before study participation. 4. The patient underwent an invasive revascularization therapy due to peripheral arterial occlusive disease (pAVK) at Fontaine stage II or higher within the last 14 days, or more than 14 days ago, either on an inpatient or outpatient basis. Alternatively, the patient is currently receiving inpatient or outpatient treatment for pAVK at Fontaine stage II or higher without a history of invasive revascularization therapy 5. Active smoker.
排除标准
- •Participants will only be included if documentation proves that the following criteria are not met at the time of enrollment: 1. Patient is not independently able to give consent. 2. Patient is pregnant or breastfeeding. 3. Patient suffers from a chronic dermatologic or respiratory disease. 4. Patient can't provide an appropriate compatible device to participate in the psychological-telemedical withdrawal consultation. 5. Judged by the investigator, the patient's participation may bear an unreasonable risk due to the patient's general condition. 6. Patient has a life expectancy of fewer than six months. 7. Preexisting present and past medical conditions or treatments could influence the study and the study evaluation.
- •8. The patient has used another smoking cessation medication within a clinical trial within the past 30 days or is enrolled in another clinical interventional study in the course of this trial. 9. The patient is expected to show missing compliance. 10. The patient is placed in an institution due to official or legal orders. 11. The patient is in a dependent relationship or employment with the sponsor, investigator, or representative.
研究者
相似试验
已完成
不适用
Evaluation of the introduction of a telemedical network to improve stroke management and secondary prevention (Trans Regional Network for stroke intervention with telemedicine)I64I61G45I63Stroke, not specified as haemorrhage or infarctionIntracerebral haemorrhageTransient cerebral ischaemic attacks and related syndromesCerebral infarctionDRKS00011696niversitätsklinikum WürzburgNeurologischen Klinik und Poliklinik7,475
Unknown
不适用
Evaluation of the effectiveness of telemedicine in the management of risk and cardiovascular problems in primary health care in CamerooCirculatory SystemCardiovascular Diseases, TelemedicinePACTR201701001964199Faculty of Medicine of Biomedical Sciences of University of Yaoundé 1182
尚未招募
Unknown
Observational study on the usefulness of telemedicine for patients initiating house dust mite sublingual immunotherapyPerennial allergic rhinitis caused by house dust miteJPRN-UMIN000053542Pauroom, Clinic for Children and Parents20
招募中
不适用
Telemedicine in the Covid-19 pandemic in Brazilin a medical clinic in the supplementary health sector in São Paulo, BrazilCovid-192019-CoVSARS-CoVTelemedicineHydroxychloroquineB04.820.504.540.150.075B04.820.504.540.150B04.820.504.540.150.113.937H02.403.840D03.633.100.810.050.180.350RBR-658khmCentro Medico Mazzei
已完成
不适用
The research of effectiveness of telemedicine for Home care in JapaSymptoms of the home careJPRN-UMIN000025145Gunma University100
